Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study

Dose: A critical factor in cancer chemotherapy

1980 • 851 citations

Cardiotoxicity Associated With High-Dose Cyclophosphamide Therapy

1981 • 461 citations

Intensive chemotherapy of small cell bronchogenic carcinoma.

1977 • 253 citations

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1980 • 241 citations

High-dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study.

1983 • 107 citations

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.

1984 • 77 citations

Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia

1982 • 54 citations

The role of autologous stem cell reconstitution in intensive therapy for resistant neoplasms.

1979 • 43 citations

Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detection

1983 • 38 citations

A manual on quantitative drug evaluation in experimental tumor systems.

1962 • 32 citations

The clinical toxicity of anticancer drugs and its prediction.

1977 • 29 citations

Intermittent high-dose cyclophosphamide (NSC-26271) treatment of stage III ovarian carcinoma.

1974 • 27 citations

A manual on quantitative drug evaluation in experimental tumor systems. I. Background, description of criteria, and presentation of quantitative therapeutic data on various classes of drugs obtained in diverse experimental tumor systems.

1962 • 24 citations

Autologous cryopreserved platelets and prophylaxis of bleeding in autologous bone marrow transplantation

1983 • 15 citations

Small cell lung cancer and the influence of chemotherapy on CFUcs in bone marrow

1984 • 7 citations

Vascular access for chemotherapy: results of a simple procedure

1983 • 1 citations